• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

14-3-3 蛋白在帕金森病模型中的差异神经保护作用。

Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease.

机构信息

Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

出版信息

Cell Death Dis. 2010;1(1):e2. doi: 10.1038/cddis.2009.4.

DOI:10.1038/cddis.2009.4
PMID:21152247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2998343/
Abstract

14-3-3 proteins are important negative regulators of cell death pathways. Recent studies have revealed alterations in 14-3-3s in Parkinson's disease (PD) and the ability of 14-3-3s to interact with alpha-synuclein (α-syn), a protein central to PD pathophysiology. In a transgenic α-syn mouse model, we found reduced expression of 14-3-3θ, ε, and γ. These same isoforms prevent α-syn inclusion formation in an H4 neuroglioma cell model. Using dopaminergic cell lines stably overexpressing each 14-3-3 isoform, we found that overexpression of 14-3-3θ, ε, or γ led to resistance to both rotenone and 1-methyl-4-phenylpyridinium (MPP(+)), while other isoforms were not protective against both toxins. Inhibition of a single protective isoform, 14-3-3θ, by shRNA did not increase vulnerability to neurotoxic injury, but toxicity was enhanced by broad-based inhibition of 14-3-3 action with the peptide inhibitor difopein. Using a transgenic C. elegans model of PD, we confirmed the ability of both human 14-3-3θ and a C. elegans 14-3-3 homolog (ftt-2) to protect dopaminergic neurons from α-syn toxicity. Collectively, these data show a strong neuroprotective effect of enhanced 14-3-3 expression - particularly of the 14-3-3θ, ε, and γ isoforms - in multiple cellular and animal models of PD, and point to the potential value of these proteins in the development of neuroprotective therapies for human PD.

摘要

14-3-3 蛋白是细胞死亡途径的重要负调控因子。最近的研究表明,帕金森病(PD)中 14-3-3 发生改变,并且 14-3-3 能够与α-突触核蛋白(α-syn)相互作用,α-syn 是 PD 病理生理学的关键蛋白。在转基因α-syn 小鼠模型中,我们发现 14-3-3θ、ε 和 γ 的表达减少。这些相同的同工型可防止α-syn 在 H4 神经胶质瘤细胞模型中形成包涵体。使用稳定过表达每种 14-3-3 同工型的多巴胺能细胞系,我们发现 14-3-3θ、ε 或 γ 的过表达可导致对鱼藤酮和 1-甲基-4-苯基吡啶(MPP(+))的抗性,而其他同工型则不能对两种毒素都有保护作用。通过 shRNA 抑制单一保护性同工型 14-3-3θ 不会增加对神经毒性损伤的易感性,但用肽抑制剂 difopein 广泛抑制 14-3-3 作用会增强毒性。使用 PD 的转基因秀丽隐杆线虫模型,我们证实了人 14-3-3θ 和秀丽隐杆线虫 14-3-3 同源物(ftt-2)均有能力保护多巴胺能神经元免受α-syn 毒性的影响。总的来说,这些数据表明增强 14-3-3 表达 - 特别是 14-3-3θ、ε 和 γ 同工型 - 在多种细胞和动物 PD 模型中具有很强的神经保护作用,并指出这些蛋白质在开发人类 PD 的神经保护疗法方面具有潜在价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/d8f8667b3a97/cddis20094f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/35736e0cb417/cddis20094f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/358b2c1635a8/cddis20094f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/1924e8c472fd/cddis20094f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/ae87176a333c/cddis20094f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/f13ce7b19556/cddis20094f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/5b5efb6328df/cddis20094f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/99acffc720e0/cddis20094f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/d8f8667b3a97/cddis20094f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/35736e0cb417/cddis20094f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/358b2c1635a8/cddis20094f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/1924e8c472fd/cddis20094f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/ae87176a333c/cddis20094f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/f13ce7b19556/cddis20094f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/5b5efb6328df/cddis20094f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/99acffc720e0/cddis20094f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdcc/3032513/d8f8667b3a97/cddis20094f8.jpg

相似文献

1
Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease.14-3-3 蛋白在帕金森病模型中的差异神经保护作用。
Cell Death Dis. 2010;1(1):e2. doi: 10.1038/cddis.2009.4.
2
Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteins.在帕金森病中观察到的14-3-3蛋白磷酸化增加降低了14-3-3蛋白的神经保护潜力。
Neurobiol Dis. 2015 Jul;79:1-13. doi: 10.1016/j.nbd.2015.02.032. Epub 2015 Apr 8.
3
14-3-3theta protects against neurotoxicity in a cellular Parkinson's disease model through inhibition of the apoptotic factor Bax.14-3-3theta 通过抑制凋亡因子 Bax 来防止细胞帕金森病模型中的神经毒性。
PLoS One. 2011;6(7):e21720. doi: 10.1371/journal.pone.0021720. Epub 2011 Jul 20.
4
14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.在帕金森病的MPTP小鼠模型中,14-3-3抑制促进多巴胺能神经元丢失,而14-3-3θ过表达促进恢复。
Neuroscience. 2015 Oct 29;307:73-82. doi: 10.1016/j.neuroscience.2015.08.042. Epub 2015 Aug 24.
5
14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model.14-3-3 减轻体内预形成纤维模型中α-突触核蛋白的聚集和毒性。
Acta Neuropathol Commun. 2021 Jan 7;9(1):13. doi: 10.1186/s40478-020-01110-5.
6
Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease.VPS41 介导的神经保护作用的功能分析在秀丽隐杆线虫和帕金森病的哺乳动物模型中的作用。
J Neurosci. 2012 Feb 8;32(6):2142-53. doi: 10.1523/JNEUROSCI.2606-11.2012.
7
14-3-3 Proteins in the regulation of rotenone-induced neurotoxicity might be via its isoform 14-3-3epsilon's involvement in autophagy.14-3-3 蛋白在鱼藤酮诱导的神经毒性中的调节作用可能与其同工型 14-3-3ε的自噬参与有关。
Cell Mol Neurobiol. 2013 Nov;33(8):1109-21. doi: 10.1007/s10571-013-9977-9. Epub 2013 Sep 4.
8
14-3-3θ phosphorylation exacerbates alpha-synuclein aggregation and toxicity.14-3-3θ磷酸化加剧α-突触核蛋白的聚集和毒性。
Neurobiol Dis. 2025 Mar;206:106801. doi: 10.1016/j.nbd.2025.106801. Epub 2025 Jan 11.
9
Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model.MPTP诱导的帕金森病小鼠模型中Srpk3表达降低与黑质α-突触核蛋白水平升高之间的关联
Mol Neurobiol. 2023 Feb;60(2):780-788. doi: 10.1007/s12035-022-03104-x. Epub 2022 Nov 12.
10
Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease.水飞蓟果实提取物在帕金森病的细胞模型和秀丽隐杆线虫模型中表现出神经保护作用。
CNS Neurosci Ther. 2024 Apr;30(4):e14515. doi: 10.1111/cns.14515. Epub 2023 Oct 31.

引用本文的文献

1
A novel 14-3-3θ phosphomimetic mouse model demonstrates social dominance defects.一种新型的14-3-3θ磷酸模拟小鼠模型表现出社会优势缺陷。
Biol Open. 2025 Jun 15;14(6). doi: 10.1242/bio.061963. Epub 2025 Jun 10.
2
Unraveling Molecular Targets for Neurodegenerative Diseases Through Models.通过模型揭示神经退行性疾病的分子靶点。
Int J Mol Sci. 2025 Mar 26;26(7):3030. doi: 10.3390/ijms26073030.
3
14-3-3θ phosphorylation exacerbates alpha-synuclein aggregation and toxicity.14-3-3θ磷酸化加剧α-突触核蛋白的聚集和毒性。

本文引用的文献

1
Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation.配体激活的过氧化物酶体增殖物激活受体γ通过上调14-3-3ε蛋白来预防缺血性脑梗死和神经元凋亡。
Circulation. 2009 Mar 3;119(8):1124-34. doi: 10.1161/CIRCULATIONAHA.108.812537. Epub 2009 Feb 16.
2
Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions.蛋白质组学分析鉴定出磷酸化依赖性α-突触核蛋白的蛋白质相互作用。
Mol Cell Proteomics. 2008 Nov;7(11):2123-37. doi: 10.1074/mcp.M800116-MCP200. Epub 2008 Jul 9.
3
Transcriptional dysregulation in a transgenic model of Parkinson disease.
Neurobiol Dis. 2025 Mar;206:106801. doi: 10.1016/j.nbd.2025.106801. Epub 2025 Jan 11.
4
The BE (2)-M17 neuroblastoma cell line: revealing its potential as a cellular model for Parkinson's disease.BE(2)-M17神经母细胞瘤细胞系:揭示其作为帕金森病细胞模型的潜力。
Front Cell Neurosci. 2024 Nov 26;18:1485414. doi: 10.3389/fncel.2024.1485414. eCollection 2024.
5
Chronic stress dysregulates the Hippo/YAP/14-3-3η pathway and induces mitochondrial damage in basolateral amygdala in a mouse model of depression.慢性应激会使 Hippo/YAP/14-3-3η 通路失调,并在抑郁小鼠模型的基底外侧杏仁核中诱导线粒体损伤。
Theranostics. 2024 Jun 11;14(9):3653-3673. doi: 10.7150/thno.92676. eCollection 2024.
6
Prospective Role of PAK6 and 14-3-3γ as Biomarkers for Parkinson's Disease.PAK6 和 14-3-3γ 作为帕金森病生物标志物的前瞻性作用。
J Parkinsons Dis. 2024;14(3):495-506. doi: 10.3233/JPD-230402.
7
14-3-3 proteins-a moonlight protein complex with therapeutic potential in neurological disorder: in-depth review with Alzheimer's disease.14-3-3蛋白——一种在神经疾病中具有治疗潜力的多功能蛋白复合物:对阿尔茨海默病的深入综述
Front Mol Biosci. 2024 Feb 5;11:1286536. doi: 10.3389/fmolb.2024.1286536. eCollection 2024.
8
Dysregulation of extracellular vesicle protein cargo in female myalgic encephalomyelitis/chronic fatigue syndrome cases and sedentary controls in response to maximal exercise.女性肌痛性脑脊髓炎/慢性疲劳综合征病例和久坐对照组在最大运动刺激下细胞外囊泡蛋白负荷的失调。
J Extracell Vesicles. 2024 Jan;13(1):e12403. doi: 10.1002/jev2.12403.
9
14-3-3γ haploinsufficiency leads to altered dopamine pathway and Parkinson's disease-like motor incoordination in mice.14-3-3γ 杂合不足导致小鼠多巴胺通路改变和类似帕金森病的运动协调障碍。
Mol Brain. 2023 Jan 5;16(1):2. doi: 10.1186/s13041-022-00990-z.
10
14-3-3θ Does Not Protect against Behavioral or Pathological Deficits in Alzheimer's Disease Mouse Models.14-3-3θ 不能预防阿尔茨海默病小鼠模型的行为或病理缺陷。
eNeuro. 2022 Jun 24;9(3). doi: 10.1523/ENEURO.0368-21.2022. Print 2022 May-Jun.
帕金森病转基因模型中的转录失调。
Neurobiol Dis. 2008 Mar;29(3):515-28. doi: 10.1016/j.nbd.2007.11.008. Epub 2007 Nov 28.
4
Overexpression of 14-3-3 protein protects pheochromocytoma cells against 1-methyl-4-phenylpyridinium toxicity.14-3-3 蛋白过表达可保护嗜铬细胞瘤细胞免受 1-甲基-4-苯基-1,2,3,6-四氢吡啶毒性的影响。
Neurosci Bull. 2006 Sep;22(5):281-7.
5
Peroxisome proliferator-activated receptor-delta upregulates 14-3-3 epsilon in human endothelial cells via CCAAT/enhancer binding protein-beta.过氧化物酶体增殖物激活受体δ通过CCAAT/增强子结合蛋白β上调人内皮细胞中的14-3-3ε。
Circ Res. 2007 Mar 16;100(5):e59-71. doi: 10.1161/01.RES.0000260805.99076.22. Epub 2007 Feb 15.
6
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.2005年至2030年人口最多国家的帕金森病患者预计人数。
Neurology. 2007 Jan 30;68(5):384-6. doi: 10.1212/01.wnl.0000247740.47667.03. Epub 2006 Nov 2.
7
alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.在A53T转基因小鼠中,α-突触核蛋白与14-3-3和突触结合蛋白-1共定位。
Acta Neuropathol. 2006 Dec;112(6):681-9. doi: 10.1007/s00401-006-0132-2. Epub 2006 Sep 7.
8
A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression.用于基于微小RNA的条件性RNA干扰和协调转基因表达的单一慢病毒载体平台。
Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13759-64. doi: 10.1073/pnas.0606179103. Epub 2006 Aug 31.
9
Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models.α-突触核蛋白阻断内质网-高尔基体运输,而Rab1可挽救帕金森病模型中的神经元损失。
Science. 2006 Jul 21;313(5785):324-8. doi: 10.1126/science.1129462. Epub 2006 Jun 22.
10
Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways.动态的14-3-3/客户蛋白相互作用整合生存和凋亡途径。
Semin Cancer Biol. 2006 Jun;16(3):193-202. doi: 10.1016/j.semcancer.2006.03.003. Epub 2006 Apr 1.